New data shows Alzheimer’s drug can slow cognitive decline

Promising data shows that an Alzheimer’s drug can slow cognitive decline.

In a phase III clinical trial, with results published Tuesday in The New England Journal of Medicine, the drug, Lecanemab — developed by Eisai and Biogen Inc. — slowed the rate of cognitive decline in patients in the early stages of the disease, making it the first drug of its kind to produce such positive trial results, a study showed.

Researchers followed nearly 1,800 patients over the course of 18 months and found the drug “resulted in moderately less decline on measures of cognition and function,” compared to patients who received a placebo.

However, the companies noted that “longer trials are warranted to determine the efficacy and safety of Lecanemab in early Alzheimer’s disease.”

PHOTO: A scientist works in a lab at Biogen Inc. in Cambridge, Mass., Nov. 5, 2016.

A scientist works in a lab at Biogen Inc. in Cambridge, Mass., Nov. 5, 2016.

Boston Globe via Getty Images, FILE

The Alzheimer’s Association said it was “encouraged” by the news and called on the U.S. Food and Drug Administration to give accelerated approval of Lecanemab.

“These peer-reviewed, published results show Lecanemab will provide patients more time to participate in daily life and live independently,” the association said in a statement. “It could mean many months more of recognizing their spouse, children and grandchildren.”

The statement continued, “Treatments that deliver tangible benefits to those living with mild cognitive impairment (MCI) due to Alzheimer’s and early Alzheimer’s dementia are as valuable as treatments that extend the lives of those with other terminal diseases”

This is a developing story. Please check back for updates.

Source ABC

A tech blog author and superhero who writes about technology and its impact on society, business, and everyday life

Related Posts

Elie Saab’s spring couture in Paris dreams of Thai escape

PARIS — Elie Saab whisked his guests away to Thailand for a Paris Fashion Week couture show Wednesday that gleamed with gold and intricate silk embroidery. Sheer diaphanous cloth floated…

Read more

Lloyd Morrisett, who helped launch ‘Sesame Street,’ dies

NEW YORK — Lloyd Morrisett, the co-creator of the beloved children’s education TV series “Sesame Street,” which uses empathy and fuzzy monsters like Abby Cadabby, Elmo and Cookie Monster to…

Read more

Why do so many older adults choose Medicare Advantage?

In 2022, 48% of Medicare beneficiaries were enrolled in Medicare Advantage plans instead of original Medicare, and experts predict that number will be higher in 2023. Medicare Advantage plans are…

Read more

North Carolina doctor sues over abortion pill access, in test case of federal power

In a lawsuit that could impact abortion access nationwide, a North Carolina doctor on Wednesday asked a federal district court to strike down the state’s restrictions on the abortion drug…

Read more

Edmunds: The pros and cons of software running your car

Software was a big theme for automakers attending CES 2023 in January. BMW, Stellantis, Volkswagen and a joint venture between Honda and Sony showed off upcoming or concept vehicles that…

Read more

Jill Biden’s inaugural wear to go on display at Smithsonian

WASHINGTON — First ladies typically donate their inaugural ball gowns to the Smithsonian Institution for its collection. Jill Biden is giving up two clothing ensembles, and neither one includes a…

Read more

Leave a Reply

Your email address will not be published. Required fields are marked *